Buzz
CVS recently confirmed that it is removing Zantac, along with its generic counterpart, from shelves. The company responsible for manufacturing the generic ranitidine, which includes store brands at Rite-Aid, Walmart, and Walgreens, is also recalling its products. However, the FDA has stated that the medication is still considered safe to use for now, raising further concerns.
Tests have discovered trace amounts of a carcinogen in the medication.
Zantac contains ranitidine as its active ingredient, and the FDA recently revealed that multiple versions of ranitidine, including both branded and generic options, were found to have small traces of NDMA, a known carcinogen.
NDMA (which is not related to the party drug MDMA) also led to a recent recall of certain blood pressure medications. In that case, the contaminant was introduced during the manufacturing process. However, with heartburn medications like ranitidine, the issue arises because ranitidine itself can produce NDMA when it interacts with enzymes in our body.
The FDA is collaborating with manufacturers to conduct more tests on the affected medications.
Despite the presence of NDMA, the amounts found are so small that the drugs are likely still safe (though with some caveats).
NDMA isn’t exclusive to medications; it’s found in the environment, including in our food and water. It forms unintentionally during some manufacturing processes, but it also occurs naturally. NDMA is present in both air and water, but the levels are so low that it generally doesn’t pose much of a concern.
The FDA has not yet mandated a recall for these medications, as there is currently no evidence to suggest that the levels of NDMA in heartburn pills are particularly hazardous. Their statement on the matter is as follows:
While NDMA can be harmful in high concentrations, the levels found in ranitidine during preliminary tests by the FDA are only slightly higher than those typically found in common foods.
This means you’ll have to make a personal decision about whether to continue using Zantac or its generic version. CVS and one generic manufacturer have decided to pull their products from the shelves, but other companies and stores are still selling theirs. The FDA has issued a warning so that consumers can make an informed choice about switching medications.
What’s the next step for you?
If you’re committed to your ranitidine and no other brand works as well for you, you may choose to continue using it. As of now, the FDA believes this is safe, though they’re still testing samples, so stay alert in case their stance changes.
However, if you feel like making a switch, that’s perfectly understandable. There are many heartburn medications available, both prescription and over-the-counter. If you’re managing digestive issues with your doctor, it’s a good idea to ask for their recommendation.
If that’s not the case, there are still plenty of alternatives. Check the remaining options on the shelves and make sure to avoid any that list ranitidine as the active ingredient. Pharmacists are often more than happy to help you choose an over-the-counter option, so don’t hesitate to ask if you need guidance.
